Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02178579 · ClinicalTrials.gov registry record
Prospective Observation of Cardiac Safety With Proteasome Inhibition
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 95
- Enrollment target
NCT02178579 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 95 participants.
The verdict
NCT02178579 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to better define and understand potential cardiac toxicities of proteasome inhibitors and to understand optimal management strategies to treat and prevent cardiovascular events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02178579
The ClinicalTrials.gov registry entry for NCT02178579 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02178579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02178579 about?
NCT02178579 is a clinical study titled "Prospective Observation of Cardiac Safety With Proteasome Inhibition". The purpose of this study is to better define and understand potential cardiac toxicities of proteasome inhibitors and to understand optimal management strategies to treat and prevent cardiovascular events.
What is the current status of trial NCT02178579?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2014-11. Estimated completion is 2019-07-15.
Who is sponsoring clinical trial NCT02178579?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.